Vaccinex, Inc. - stock earnings
VCNX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.9 million USD | 20000 USD |
| 2023Q2 | -7.1 million USD | ? USD |
| 2023Q1 | -4.9 million USD | 550000 USD |
| 2022Q4 | -5.0 million USD | 50000 USD |
| 2022Q3 | -4.7 million USD | 50000 USD |
| 2022Q2 | -5.4 million USD | ? USD |
| 2022Q1 | -4.6 million USD | ? USD |
| 2021Q4 | -4.6 million USD | 850000 USD |
| 2021Q3 | -5.2 million USD | 50000 USD |
| 2021Q2 | -6.0 million USD | ? USD |
| 2021Q1 | -6.6 million USD | 850000 USD |
| 2020Q4 | -6.4 million USD | 50000 USD |
| 2020Q3 | -8.8 million USD | 50000 USD |
| 2020Q2 | -6.5 million USD | ? USD |
| 2020Q1 | -7.1 million USD | ? USD |
| 2019Q4 | -6.3 million USD | ? USD |
| 2019Q3 | -7.6 million USD | 404000 USD |
| 2019Q2 | -8.8 million USD | 25000 USD |
| 2019Q1 | -9.1 million USD | 94000 USD |
| 2018Q4 | -8.4 million USD | 194000 USD |
| 2018Q3 | -6.6 million USD | 198000 USD |
| 2018Q2 | -6.6 million USD | 126000 USD |
| 2018Q1 | -7.9 million USD | 206000 USD |
| 2017Q4 | -2.6 million USD | 90000 USD |
| 2017Q3 | -5.5 million USD | ? USD |
| 2017Q2 | -4.9 million USD | ? USD |
| 2017Q1 | -5.7 million USD | ? USD |
| 2016Q4 | -13.9 million USD | 316000 USD |
VCNX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.0 million USD | 620000 USD |
| 2022 | -19.7 million USD | 100000 USD |
| 2021 | -23.2 million USD | 900000 USD |
| 2020 | -29.3 million USD | 50000 USD |
| 2019 | -32.0 million USD | 523000 USD |
| 2018 | -29.5 million USD | 724000 USD |
| 2017 | -18.7 million USD | 90000 USD |
| 2016 | -13.9 million USD | 316000 USD |
VCNX
Price: $6.05
52 week price:
Earnings Per Share: -83.86 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 494085
Market Capitalization: 7.9 million